A prospective, multicenter study assessing the effects of a newly introduced bronchodilator on pulmonary function, dyspnea, quality of life (QOL), six minutes' walk test, and physical activity in patients with treatment-naïve chronic obstructive pulmonary disease (COPD)
Latest Information Update: 03 Jul 2020
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
Most Recent Events
- 03 Jul 2020 New trial record
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society